Teladoc Health, Inc. (TDOC) Q3 2026 earnings results
Teladoc Health, Inc. (TDOC) reported Q3 2026 results on Oct 28, 2026, 4:04:45 PM ET: GAAP EPS -$0.15 vs. -$0.19 expected (beat by 19.6%); revenue $605.10M vs. $590.09M expected (beat by 2.5%). Outlook: For the fourth quarter of 2026, the company expects revenue of $569 - $615 million and a net loss per share of ($0.23) - ($0.03).
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.15 | -$0.19 | Beat by 19.6% |
| Revenue | $605.10M | $590.09M | Beat by 2.5% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 28, 2026, 4:04:45 PM ET. Nexqual published them 35 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 3.4% from $626.44M; GAAP diluted EPS was -$0.15 vs. -$0.28 (+46.4%).
Stock reaction
The results came out after the market closed. TDOC closed at $8.73 on October 29, 2026, up 26.9% from its $6.88 close on October 28, 2026 before the results.
Questions and answers
Did Teladoc Health, Inc. beat earnings expectations?
Yes. Teladoc Health, Inc. reported GAAP EPS of -$0.15 against an average analyst estimate of -$0.19 (beat by 19.6%), and revenue of $605.10M against $590.09M expected (beat by 2.5%).
What were Teladoc Health, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.15 and revenue of $605.10M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 3.4% from $626.44M; GAAP diluted EPS was -$0.15 vs. -$0.28 (+46.4%).
When did Teladoc Health, Inc. report Q3 2026 earnings?
Oct 28, 2026, 4:04:45 PM ET, in an SEC 8-K filing (Item 2.02).
How did TDOC stock react to the earnings?
The results came out after the market closed. TDOC closed at $8.73 on October 29, 2026, up 26.9% from its $6.88 close on October 28, 2026 before the results.
What did Teladoc Health, Inc. say about its outlook?
For the fourth quarter of 2026, the company expects revenue of $569 - $615 million and a net loss per share of ($0.23) - ($0.03).
More on TDOC
TDOC stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 28, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:08 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:08 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt